Letters The “Saatchi bill”

“Saatchi bill”: legal hurdles and clinical irrelevance

BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g3146 (Published 14 May 2014) Cite this as: BMJ 2014;348:g3146
  1. Santhanam Sundar, consultant oncologist1
  1. 1Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK
  1. sundar{at}oncology.org

The “Saatchi law” was drafted with the noblest of intentions but it faces serious hurdles in achieving the aim of promoting innovative treatments.1

Firstly, the bill needs to be reconciled with various mandatory EU directives on medicinal products.2 As the Medicines and Healthcare Products Regulatory Agency states, the EU “Directive 2001/83/EC relating to medicinal products …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe